The Latest Cardiac and Vascular News
SUNNYVALE, Calif., June 22, 2021 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, recently announced the opening of a new office in Plymouth, Minnesota, to accommodate growing demand for TransCarotid Artery Revascularization (TCAR) and to access the […]
Copenhagen and Aarhus, Denmark, 23 June 2021 – Draupnir Bio (“Draupnir”), a biotechnology company developing small molecule modulators of PCSK9 to transform the treatment of heart disease, today announces the appointment of Andrew Hotchkiss as Chief Executive Officer (CEO). Andrew brings more than 30 years of global experience in the pharmaceutical and biotechnology industries. He joins […]
EATONTOWN, N.J., June 22, 2021 /PRNewswire/ — Angel Medical Systems, Inc., (dba AngelMed) announced today the departure of Gordie Nye as CEO of the company effective immediately. He will be succeeded by Brad Snow, an experienced leader in the medical device industry who has served in a variety of senior roles at several successful med-tech startups. […]
MENLO PARK, Calif., June 22, 2021 /PRNewswire/ — Ablacon, Inc., developer of an advanced mapping system to guide the treatment of atrial fibrillation (AF), announced today that is has promoted Martin Grasse to the position of Chief Executive Officer. Former CEO Duke Rohlen will continue with the company as Executive Chairman. “Marty has demonstrated exceptional leadership capabilities […]
Proven sales leader brings more than 20 years of healthcare experience to help Implicity accelerate its expansion into the US market CAMBRIDGE, Mass., June 22, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, today announced the addition of Tim Laird as Vice President of Sales–North America. Laird […]
George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer EDEN PRAIRIE, Minn., June 22, 2021 (GLOBE NEWSWIRE) — Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric […]
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) — Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the closing of its previously announced initial public offering of 16,141,157 shares of its common stock, which includes 2,105,368 shares […]
Dr. Azeem Latib and Doug Teany join to bring deep subject matter expertise in coronary and structural heart procedures as well as robotic surgery CLEVELAND, June 21, 2021 /PRNewswire/ — Centerline Biomedical, Inc. (Centerline), a spinoff of Cleveland Clinic, today announced the appointment of two key advisors. As Centerline launches its flagship Intra-Operative […]
Resulting from More than a Decade of Clinical Research, Company Unveils Non-Invasive Approach to Identify, and New Care Pathways to Address Heart Disease Using Artificial Intelligence NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, launched today with $43 million in Series B funding and […]
BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Technologies, LLC, a global innovator in the development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals, today announced the appointment of Frank Scholz, Ph.D., as Senior Vice President and Chief Operating Officer. In this new position, he brings more than 20 years of relevant operational experience […]
